WATERTOWN, Mass., Aug. 09, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV); (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for eye diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback